Header Logo

Connection

ADEL K EL-NAGGAR to Precipitin Tests

Back to Details
This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Precipitin Tests.
ADEL K EL-NAGGAR
Connection Strength
0.014
Precipitin Tests
  1. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells. Clin Cancer Res. 2004 Jan 15; 10(2):658-67.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.